rs121913105
|
|
|
0.850 |
GeneticVariation |
BEFREE |
K650M/E substitutions in the Fibroblast growth factor receptor 3 (FGFR3) are associated with Severe Achondroplasia with Developmental Delay and Acanthosis Nigricans (SADDAN) and Thanatophoric Dysplasia type II (TDII), respectively.
|
29242050 |
2018 |
rs121913105
|
|
|
0.850 |
GeneticVariation |
BEFREE |
Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation.
|
18076102 |
2008 |
rs121913105
|
|
|
0.850 |
GeneticVariation |
BEFREE |
Two missense mutations in this codon are known to result in strong constitutive activation of the FGFR3 tyrosine kinase and cause three different skeletal dysplasia syndromes-thanatophoric dysplasia type II (TD2) (A1948G [Lys650Glu]) and SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) syndrome and thanatophoric dysplasia type I (TD1) (both due to A1949T [Lys650Met]).
|
11055896 |
2000 |
rs121913105
|
|
|
0.850 |
GeneticVariation |
UNIPROT |
We refer to the phenotype caused by the Lys650Met mutation as "severe achondroplasia with developmental delay and acanthosis nigricans" (SADDAN) because it differs significantly from the phenotypes of other known FGFR3 mutations.
|
10053006 |
1999 |
rs121913105
|
|
|
0.850 |
GeneticVariation |
BEFREE |
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.
|
10377013 |
1999 |
rs121913105
|
|
|
0.850 |
GeneticVariation |
BEFREE |
We refer to the phenotype caused by the Lys650Met mutation as "severe achondroplasia with developmental delay and acanthosis nigricans" (SADDAN) because it differs significantly from the phenotypes of other known FGFR3 mutations.
|
10053006 |
1999 |
rs121913105
|
|
C |
0.850 |
CausalMutation |
CLINVAR |
|
|
|
rs121913116
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia.
|
16912704 |
2006 |
rs121913482
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913483
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs28931614
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs28933068
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs4647924
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587779383
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Two missense mutations in this codon are known to result in strong constitutive activation of the FGFR3 tyrosine kinase and cause three different skeletal dysplasia syndromes-thanatophoric dysplasia type II (TD2) (A1948G [Lys650Glu]) and SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) syndrome and thanatophoric dysplasia type I (TD1) (both due to A1949T [Lys650Met]).
|
11055896 |
2000 |
rs78311289
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Two missense mutations in this codon are known to result in strong constitutive activation of the FGFR3 tyrosine kinase and cause three different skeletal dysplasia syndromes-thanatophoric dysplasia type II (TD2) (A1948G [Lys650Glu]) and SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) syndrome and thanatophoric dysplasia type I (TD1) (both due to A1949T [Lys650Met]).
|
11055896 |
2000 |